Eisai Seeks Formal Japanese Approval For Lunesta Insomnia Drug
This article was originally published in PharmAsia News
Executive Summary
Eisai has filed for Japanese Ministry of Health, Labor and Welfare approval of its drug to treat chronic insomnia, SEP-190 (eszopiclone)